Norcliffe Capital

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

1 Jul 2025

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

Laverock Therapeutics is developing programmable gene control technologies that enable advanced therapies to respond dynamically to disease, improving precision, safety and effectiveness in cell-based treatments.

Norcliffe Capital

- Life Sciences
1(12 months)
norcliffe.capital
Update Information

More venture news

2 Mar 2026
Payr raises a £1.5m seed round led by Ingenii Capital for credit card-enabled rent payments
SeedFintech
2 Mar 2026
Ivee raises a seven-figure seed round from Social Impact Enterprises and angels for AI upskilling and talent platform
SeedHR
25 Feb 2026
Kinfolk raises a £5m seed round led by AlbionVC to shift manual HR workflows with agentic AI
SeedHR

Norcliffe Capital

Investment Portfolio

Laverock Therapeutics raises over £20m in expanded seed round led by Calculus Capital to advance gene control therapies

More venture news

Payr raises a £1.5m seed round led by Ingenii Capital for credit card-enabled rent payments

Ivee raises a seven-figure seed round from Social Impact Enterprises and angels for AI upskilling and talent platform

Kinfolk raises a £5m seed round led by AlbionVC to shift manual HR workflows with agentic AI